Table 4.

 Outcome after follow-up of 1055 patients with newly diagnosed second stage human African trypanosomiasis treated with eflornithine. Values are percentages unless stated otherwise

Outcome	No of patients	Evaluable group (n=924)	Whole cohort (n=1055)
Cured at 24 months	403	43.6	38.2
Probably cured at 24 months*	29	3.1	2.7
Probably cured (partial follow-up)†	391	42.3	37.1
No follow-up	131	—	12.4
Died during treatment	16‡	1.7	1.5
Relapsed (all in second stage)	70	7.6	6.6
Probably relapsed (died of disease)	15	1.6	1.4

*In good general health but refusing to travel for final laboratory assessment.

†11 patients died of non-disease causes (for example, war) during follow-up.

‡One death was unrelated to treatment.